Louisiana State Employees Retirement System’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.25M Buy
26,500
+400
+2% +$41.8K 0.05% 356
2026
Q1
$2.75M Sell
26,100
-800
-3% -$70.8K 0.05% 378
2025
Q4
$2.35M Hold
26,900
0.04% 439
2025
Q3
$1.79M Sell
26,900
-2,100
-7% -$119K 0.03% 614
2025
Q2
$1.6M Buy
29,000
+900
+3% +$43.2K 0.03% 644
2025
Q1
$1.36M Sell
28,100
-700
-2% -$29.3K 0.03% 750
2024
Q4
$1.11M Buy
28,800
+300
+1% +$13.1K 0.02% 926
2024
Q3
$1.28M Buy
+28,500
New +$1.15M 0.02% 843

Other funds holding PTGX

Louisiana State Employees Retirement System's PTGX Position: Q2 2026 in Review

Louisiana State Employees Retirement System increased its Protagonist Therapeutics (PTGX) stake by 1.5% in Q2 2026, buying an estimated $41.8K and bringing the position to 26,500 shares worth $3.25M. The position accounts for 0.05% of the portfolio, ranked #356.

Louisiana State Employees Retirement System first reported a position in PTGX in Q3 2024 and has held it in 8 quarters since. 65 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • Louisiana State Employees Retirement System held 26,500 shares of Protagonist Therapeutics worth $3.25M as of Q2 2026.
  • Louisiana State Employees Retirement System bought 400 Protagonist Therapeutics shares in Q2 2026, an estimated $41.8K.
  • Protagonist Therapeutics made up 0.05% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #356 holding.
  • Louisiana State Employees Retirement System first reported a position in Protagonist Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 65 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.